vs
Arq, Inc.（ARQ）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Arq, Inc.的1.2倍（$35.5M vs $29.4M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 8.8%），Arq, Inc.自由现金流更多（$-3.5M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 16.4%）
Arq Inc是一家可持续发展技术企业，主营将煤矿开采废弃物加工为高价值低碳固体燃料及工业碳产品，服务能源、建筑、制造等领域客户，核心市场覆盖北美及欧洲主要地区，致力于帮助工业客户减少废弃物、降低碳排放。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ARQ vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$29.4M
营收增速更快
RXRX
高出672.9%
8.8%
自由现金流更多
ARQ
多$43.8M
$-47.3M
两年增速更快
RXRX
近两年复合增速
16.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.4M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | 13.6% | 59.8% |
| 营业利润率 | -174.1% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 8.8% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $-1.20 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARQRXRX
| Q4 25 | $29.4M | $35.5M | ||
| Q3 25 | $35.1M | $5.2M | ||
| Q2 25 | $28.6M | $19.2M | ||
| Q1 25 | $27.2M | $14.7M | ||
| Q4 24 | $27.0M | $4.5M | ||
| Q3 24 | $34.8M | $26.1M | ||
| Q2 24 | $25.4M | $14.4M | ||
| Q1 24 | $21.7M | $13.8M |
净利润ARQRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-653.0K | $-162.3M | ||
| Q2 25 | $-2.1M | $-171.9M | ||
| Q1 25 | $203.0K | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $1.6M | $-95.8M | ||
| Q2 24 | $-2.0M | $-97.5M | ||
| Q1 24 | $-3.4M | $-91.4M |
毛利率ARQRXRX
| Q4 25 | 13.6% | 59.8% | ||
| Q3 25 | 28.8% | -183.8% | ||
| Q2 25 | 33.3% | -4.9% | ||
| Q1 25 | 36.4% | -48.0% | ||
| Q4 24 | 36.3% | -181.4% | ||
| Q3 24 | 38.6% | 53.7% | ||
| Q2 24 | 32.2% | 36.2% | ||
| Q1 24 | 36.9% | 19.1% |
营业利润率ARQRXRX
| Q4 25 | -174.1% | -304.8% | ||
| Q3 25 | -2.4% | -3327.6% | ||
| Q2 25 | -5.4% | -916.8% | ||
| Q1 25 | 2.4% | -1297.9% | ||
| Q4 24 | 1.5% | -4042.4% | ||
| Q3 24 | 5.8% | -377.1% | ||
| Q2 24 | -5.6% | -697.4% | ||
| Q1 24 | -13.7% | -698.4% |
净利率ARQRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -1.9% | -3135.3% | ||
| Q2 25 | -7.5% | -894.2% | ||
| Q1 25 | 0.7% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 4.7% | -367.5% | ||
| Q2 24 | -7.7% | -676.6% | ||
| Q1 24 | -15.7% | -662.4% |
每股收益（稀释后）ARQRXRX
| Q4 25 | $-1.20 | $-0.17 | ||
| Q3 25 | $-0.02 | $-0.36 | ||
| Q2 25 | $-0.05 | $-0.41 | ||
| Q1 25 | $0.00 | $-0.50 | ||
| Q4 24 | $-0.03 | $-0.56 | ||
| Q3 24 | $0.04 | $-0.34 | ||
| Q2 24 | $-0.06 | $-0.40 | ||
| Q1 24 | $-0.09 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.6M | $743.3M |
| 总债务越低越好 | $28.7M | $9.6M |
| 股东权益账面价值 | $168.0M | $1.1B |
| 总资产 | $230.6M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ARQRXRX
| Q4 25 | $6.6M | $743.3M | ||
| Q3 25 | $7.0M | $659.8M | ||
| Q2 25 | $7.0M | $525.1M | ||
| Q1 25 | $6.3M | $500.5M | ||
| Q4 24 | $13.5M | $594.4M | ||
| Q3 24 | $48.7M | $427.6M | ||
| Q2 24 | $28.5M | $474.3M | ||
| Q1 24 | $35.2M | $296.3M |
总债务ARQRXRX
| Q4 25 | $28.7M | $9.6M | ||
| Q3 25 | $26.1M | $11.9M | ||
| Q2 25 | $28.9M | $14.2M | ||
| Q1 25 | $27.1M | $16.4M | ||
| Q4 24 | $25.1M | $19.0M | ||
| Q3 24 | $21.6M | $20.5M | ||
| Q2 24 | $22.2M | $22.9M | ||
| Q1 24 | $22.6M | — |
股东权益ARQRXRX
| Q4 25 | $168.0M | $1.1B | ||
| Q3 25 | $217.2M | $1.0B | ||
| Q2 25 | $216.8M | $919.1M | ||
| Q1 25 | $218.2M | $933.9M | ||
| Q4 24 | $217.3M | $1.0B | ||
| Q3 24 | $218.1M | $524.6M | ||
| Q2 24 | $189.6M | $584.4M | ||
| Q1 24 | $175.2M | $401.2M |
总资产ARQRXRX
| Q4 25 | $230.6M | $1.5B | ||
| Q3 25 | $277.9M | $1.4B | ||
| Q2 25 | $284.5M | $1.3B | ||
| Q1 25 | $283.7M | $1.3B | ||
| Q4 24 | $284.4M | $1.4B | ||
| Q3 24 | $280.0M | $726.5M | ||
| Q2 24 | $248.6M | $775.9M | ||
| Q1 24 | $229.8M | $557.8M |
负债/权益比ARQRXRX
| Q4 25 | 0.17× | 0.01× | ||
| Q3 25 | 0.12× | 0.01× | ||
| Q2 25 | 0.13× | 0.02× | ||
| Q1 25 | 0.12× | 0.02× | ||
| Q4 24 | 0.12× | 0.02× | ||
| Q3 24 | 0.10× | 0.04× | ||
| Q2 24 | 0.12× | 0.04× | ||
| Q1 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-3.5M | $-47.3M |
| 自由现金流率自由现金流/营收 | -12.0% | -133.1% |
| 资本支出强度资本支出/营收 | 2.7% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-11.3M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ARQRXRX
| Q4 25 | $-2.8M | $-46.1M | ||
| Q3 25 | $5.3M | $-117.4M | ||
| Q2 25 | $527.0K | $-76.4M | ||
| Q1 25 | $-5.8M | $-132.0M | ||
| Q4 24 | $5.2M | $-115.4M | ||
| Q3 24 | $7.7M | $-59.2M | ||
| Q2 24 | $-3.0M | $-82.2M | ||
| Q1 24 | $526.0K | $-102.3M |
自由现金流ARQRXRX
| Q4 25 | $-3.5M | $-47.3M | ||
| Q3 25 | $3.1M | $-117.6M | ||
| Q2 25 | $-1.4M | $-79.6M | ||
| Q1 25 | $-9.5M | $-133.8M | ||
| Q4 24 | $-37.8M | $-116.7M | ||
| Q3 24 | $-5.8M | $-63.8M | ||
| Q2 24 | $-22.1M | $-83.4M | ||
| Q1 24 | $-9.1M | $-109.0M |
自由现金流率ARQRXRX
| Q4 25 | -12.0% | -133.1% | ||
| Q3 25 | 8.8% | -2272.5% | ||
| Q2 25 | -4.7% | -413.9% | ||
| Q1 25 | -34.9% | -907.4% | ||
| Q4 24 | -139.6% | -2567.7% | ||
| Q3 24 | -16.5% | -244.6% | ||
| Q2 24 | -87.1% | -578.5% | ||
| Q1 24 | -41.7% | -789.9% |
资本支出强度ARQRXRX
| Q4 25 | 2.7% | 3.5% | ||
| Q3 25 | 6.3% | 4.7% | ||
| Q2 25 | 6.6% | 16.4% | ||
| Q1 25 | 13.6% | 12.4% | ||
| Q4 24 | 158.9% | 28.6% | ||
| Q3 24 | 38.7% | 17.5% | ||
| Q2 24 | 75.5% | 8.2% | ||
| Q1 24 | 44.1% | 48.2% |
现金转化率ARQRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -28.59× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.76× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
